Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

Massie, Barry M., Carson, Peter E., McMurray, John J., Komajda, Michel, McKelvie, Robert, Zile, Michael R., Anderson, Susan, Donovan, Mark, Iverson, Erik, Staiger, Christoph, Ptaszynska, Agata·2008·New England Journal of Medicine

DOI 10.1056/nejmoa0805450

Cited by (1,001)

Items 501–600 of 1,001

Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction
Heng Zeng, Jian‐Xiong Chen · 2019 · Journal of Cardiovascular Pharmacology
Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
Antoni Bayés‐Genís, Oriol Iborra Egea, Giosafat Spitaleri, Mar Domingo, Elena Revuelta‐López, Pau Codina, Germán Cediel, Evelyn Santiago‐Vacas, Adriana Cserkóová, Domingo Andrés Pascual-Figal et al. · 2021 · Scientific Reports
Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction
Sylvestre Maréchaux, Marie Six-Carpentier, Nadia Bouabdallaoui, David Montaigne, Jean-Jacques Bauchart, Frédéric Mouquet, Jean-Luc Auffray, Thierry Le Tourneau, Philippe Asseman, Thierry H. LeJemtel et al. · 2010 · Heart and Vessels
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Stefan D. Anker, Javed Butler, Muhammad Usman, Gerasimos S Filippatos, João Pedro Ferreira, Edimar Alcides Bocchi, Michael Böhm, Hans‐Peter Brunner‐La Rocca, Dong‐Ju Choi, Vijay Chopra et al. · 2022 · Nature Medicine
Aldosterone Antagonists and Outcomes in Real-World Older Patients With Heart Failure and Preserved Ejection Fraction
Kanan Patel, Gregg C. Fonarow, Dalane W. Kitzman, Inmaculada Aban, Thomas E. Love, Richard M. Allman, Mihai Gheorghiade, Ali Ahmed · 2013 · JACC Heart Failure
Striking Volume Intolerance Is Induced by Mimicking Arterial Baroreflex Failure in Normal Left Ventricular Function
Kouta Funakoshi, Kazuya Hosokawa, Takuya Kishi, Tomomi Ide, Kenji Sunagawa · 2013 · Journal of Cardiac Failure
From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress
Constantijn Franssen, H. Sophia Chen, Nazha Hamdani, Walter J. Paulus · 2015 · Heart
Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction
Sanjiv Jayendra Shah · 2017 · Journal of Cardiovascular Translational Research
Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design
Mark B Loeb, Hisham Dokainish, Antonio Dans, Lia M. Palileo‐Villanueva, Ambuj Roy, Kamilu Musa Karaye, Jun Zhu, Yan Liang, Fastone Mathew Goma, Albertino Antonio Moura Damasceno et al. · 2019 · American Heart Journal
Depressed Myocardial Energetic Efficiency Increases Risk of Incident Heart Failure: The Strong Heart Study
Maria Angela Losi, Raffaele Izzo, Costantino Mancusi, Wenyu Wang, Mary J. Roman, Elisa T. Lee, Barbara V. Howard, Richard B. Devereux, Giovanni DE SIMONE · 2019 · Journal of Clinical Medicine
Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
Robert J. Henning · 2019 · World Journal of Cardiology
Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction
Jun Gu, Jianan Pan, Hao Lin, Junfeng Zhang, Changqian Wang · 2020 · International Journal of Cardiology
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes
Mazen Saadi Albaghdadi, Mihai Gheorghiade, Bertram Pitt · 2011 · European Heart Journal
History of Atrial Fibrillation as a Risk Factor in Patients With Heart Failure and Preserved Ejection Fraction
Oludamilola W. Oluleye, Thomas S. Rector, Sithu Win, John J.V. McMurray, Michael R. Zile, Michel Komajda N, Robert Samuel McKelvie, Barry M. Massie, Peter E. Carson, Inder S. Anand · 2014 · Circulation Heart Failure
Sex, Drugs, and Heart Failure: A Sex-Sensitive Review of the Evidence Base Behind Current Heart Failure Clinical Guidelines
Anna Levinsson, Marie‐Pierre Dubé, Jean‐Claude Tardif, Simon de Denus · 2018 · ESC Heart Failure
Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
Adam Kenneth McDiarmid, Peter Swoboda, Bara Erhayiem, Katrina Bounford, Petra Bijsterveld, Keith Tyndall, Graham J. Fent, Pankaj Garg, Laura Elizabeth Dobson, Tarique A Musa et al. · 2019 · Journal of the American Heart Association
Current status of heart failure: global and Korea
Jin Joo Park, Dong‐Ju Choi · 2020 · The Korean Journal of Internal Medicine
The Heart Failure Spectrum
Gilles W. De Keulenaer, Dirk L. Brutsaert · 2009 · Circulation
Clinical Trials in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction
John G.F. Cleland, Pierpaolo Pellicori, Riet Dierckx · 2014 · Heart Failure Clinics
Diastology 2010: clinical approach to diastolic heart failure
Hirotsugu Yamada, Allan L. Klein · 2010 · Journal of Echocardiography
Should There Be Sex-Specific Criteria for the Diagnosis and Treatment of Heart Failure?
Lawrence E. Greiten, Sara J. Holditch, Shivaram P. Arunachalam, Virginia M. Miller · 2013 · Journal of Cardiovascular Translational Research
Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure
Kazuo Komamura · 2013 · Cardiology Research and Practice
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Stephan von Haehling, Birgit Aßmus, Tarek Bekfani, Elke Dworatzek, Frank Edelmann, Djawid Hashemi, Kristian Hellenkamp, Tibor Kempf, Philipp Raake, Katharina Andrea Schütt et al. · 2024 · Clinical Research in Cardiology
Fahreignung bei kardiovaskulären Erkrankungen
H. H. Klein, A. Krämer, Burkert Mathias Pieske, Hans‐Joachim Trappe, H. de Vries · 2010 · Der Kardiologe
Angiotensin Receptor Blockers and Outcomes in Real-World Older Patients with Heart Failure and Preserved Ejection Fraction: A Propensity-Matched Inception Cohort Clinical Effectiveness Study
Kanan Patel, Gregg C. Fonarow, Dalane W. Kitzman, Inmaculada Aban, Thomas E. Love, Richard M. Allman, Mihai Gheorghiade, Ali Ahmed · 2012 · European Journal of Heart Failure
Diastolic Heart Failure: Progress, Treatment Challenges, and Prevention
Philip Wood, Sanaz Piran, Peter P. Liu · 2011 · Canadian Journal of Cardiology
Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials
Yanmei Chen, He Wang, Yongkang Lu, Xiaobo Huang, Yulin Liao, Jianping Bin · 2015 · BMC Medicine
Comparison of Predictors of Heart Failure–Related Hospitalization or Death in Patients With Versus Without Preserved Left Ventricular Ejection Fraction
Ashvarya Mangla, John Kane, Elijah Beaty, DeJuran Richardson, Lynda H. Powell, James E. Calvin · 2013 · The American Journal of Cardiology
Usefulness of Tissue Doppler Imaging‐Myocardial Performance Index in the Evaluation of Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction
Hyungseop Kim, Hyuck‐Jun Yoon, Hyoung‐Seob Park, Yun‐Kyeong Cho, Chang‐Wook Nam, Seung‐Ho Hur, Yoon-Nyun Kim, Kwon‐Bae Kim · 2011 · Clinical Cardiology
Imaging of Diastolic Dysfunction in Community-Based Epidemiological Studies and Randomized Controlled Trials of HFpEF
Michael Chetrit, Paul C Cremer, Allan L. Klein · 2020 · JACC. Cardiovascular imaging
Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)
Kartik Gupta, Rajat Kalra, Indranee N. Rajapreyar, Joanna M. Joly, Mike Pate, Marc Garret Cribbs, Sameer Ather, Sumanth D. Prabhu, Navkaranbir Singh Bajaj · 2020 · The American Journal of Cardiology
Inhibition of HSP90 S‐nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway
Xiyue Zhang, Yihua Zhang, Miao Qing, Zhiguang Shi, Lulu Hu, Shangmin Liu, Jie Gao, Shuang Zhao, Hongshan Chen, Zhengrong Huang et al. · 2021 · British Journal of Pharmacology
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction — Results of the Aldo-DHF trial
Frank Edelmann, Götz Gelbrich, André Duvinage, Raoul Stahrenberg, Anneke Behrens, Christiane Prettin, Elisabeth Kraigher‐Krainer, Albrecht G. Schmidt, Hans‐Dirk Düngen, W. Kamke et al. · 2013 · International Journal of Cardiology
Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial
Roberto Marchioli, Giacomo Levantesi, Maria Giuseppina Silletta, Simona Barlera, Marino Bernardinangeli, Emanuele Carbonieri, Francesco Cosmi, Maria Grazia Franzosi, Roberto Latini, Donata Lucci et al. · 2009 · Expert Review of Cardiovascular Therapy
Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data
UK HARP-III Collaborative Group, PK Judge, Richard Haynes, William Guy Herrington, BC Storey, N Staplin, A Bethel, L Bowman, N Brunskill, P Cockwell et al. · 2016 · Nephrology Dialysis Transplantation
A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
Markus Wallner, Deborah Eaton, Remus M. Berretta, Giulia Borghetti, Jichuan Wu, Sandy T. Baker, Eric A. Feldsott, Thomas E. Sharp, Sadia Mohsin, Mark A. Oyama et al. · 2017 · Scientific Reports
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
Edoardo Gronda, Emilio Vanoli, Massimo Iacoviello · 2020 · European Heart Journal Supplements
Prognostic Significance of the HFA-PEFF Score in Patients with Heart Failure with Preserved Ejection Fraction
Yohei Sotomi, Katsuomi Iwakura, Shungo Hikoso, Koichi Inoue, Toshinari Onishi, Masato Okada, Kenshi Fujii, Atsunori Okamura, Shunsuke Tamaki, Masamichi Yano et al. · 2021 · ESC Heart Failure
The Impact of Extra Cardiac Comorbidities on Pressure Volume Relations in Heart Failure and Preserved Ejection Fraction
Dmitry Abramov, Kunlun He, Jie Wang, Daniel Burkhoff, Mathew S. Maurer · 2011 · Journal of Cardiac Failure
Effects of Direct Renin Inhibition on Myocardial Fibrosis and Cardiac Fibroblast Function
Hui Zhi, Ivan Luptak, Gaurav Alreja, Jianru Shi, Jian Guan, Nicole Kosik, Jacob Joseph · 2013 · PLoS ONE
Heart Failure with Preserved Ejection Fraction: Pathophysiology and Emerging Therapies
Aaron M. From, Barry A. Borlaug · 2010 · Cardiovascular Therapeutics
Association of Low Plasma Adiponectin With Early Diastolic Dysfunction
Smita Negi, Euy-Myoung Jeong, Irfan Shukrullah, Mihai Raicu, Samuel C. Dudley · 2012 · Congestive Heart Failure
Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure
Connor A. Emdin, Thomas Callender, Jun Cao, John J.V. McMurray, Kazem Rahimi · 2015 · The American Journal of Cardiology
Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease
Santiago Reyes, Jasmina Varagić, Sarfaraz Ahmad, Jessica L. VonCannon, Neal D. Kon, Hao Wang, Leanne Groban, Che Ping Cheng, Louis J. Dell’Italia, Carlos Maria Ferrario · 2017 · Current Hypertension Reports
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro–B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction
Gianluigi Savarese, Nicola Orsini, Camilla Hage, Ulf Dahlström, Ola Vedin, Giuseppe M.C. Rosano, Lars H. Lund · 2018 · Journal of Cardiac Failure
Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
Bharathi Upadhya, Mark J. Haykowsky, Dalane W. Kitzman · 2018 · Heart Failure Reviews
The year in cardiology 2018: heart failure
John G.F. Cleland, Dirk Jan van Veldhuisen, Piotr P. Ponikowski · 2019 · European Heart Journal
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Darryl P. Leong, John J.V. McMurray, Philip G. Joseph, Salim Yusuf · 2019 · Journal of the American College of Cardiology
Biomarker profiling for risk of future heart failure (HFpEF) development
Chris J Watson, Joe Gallagher, Mark Wilkinson, Adam Russell‐Hallinan, Isaac Tea, Stephanie James, James O’Reilly, Eoin O’Connell, Shuaiwei Zhou, Mark T. Ledwidge et al. · 2021 · Journal of Translational Medicine
Mitochondrial function, dynamics and quality control in the pathophysiology of HFpEF
Andrea del Campo, Gonzalo Perez, Pablo Castro, Valentina Parra, Hugo Verdejo · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction
Micha Tobias Maeder, David M. Kaye · 2010 · International Journal of Cardiology
Updates in Cardiorenal Syndrome
Wendy I. McCallum, Jeffrey Moore Testani · 2023 · Medical Clinics of North America
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, Georg Spinka, Georg Goliasch, Henrike Arfsten, Ramy Abdel Mawgoud, Cornelia Gabler, Guido Strunk, Christian Hengstenberg et al. · 2023 · European Journal of Preventive Cardiology
Body Mass Index and Cardiorenal Outcomes in the EMPEROR-Preserved Trial: Principal Findings and Meta-Analysis with the DELIVER Trial
Naveed A. Sattar, Javed Butler, Matthew M.Y. Lee, Josephine Harrington, Abhinav Sharma, Faiez M. Zannad, Gerasimos S Filippatos, Subodh Verma, James L. Januzzi, João Pedro Ferreira et al. · 2024 · European Journal of Heart Failure
Noncardiac Comorbidities in Heart Failure With Preserved Ejection Fraction – A Commonly Ignored Fact –
Ming Liu, Fang Fang, Cheuk‐Man Yu · 2015 · Circulation Journal
Heart failure with a normal ejection fraction: new developments
Gabriel Wai‐Kwok Yip, Michael Paul Frenneaux, John Elsby Sanderson · 2009 · Heart
What global diastolic function is, what it is not, and how to measure it
Charles S. Chung, Leonid Shmuylovich, Sándor J. Kovács · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
The use of supercritical anti-solvent (SAS) technique for preparation of Irbesartan-Pluronic® F-127 nanoparticles to improve the drug dissolution
Ehsan Adeli · 2016 · Powder Technology
Pharmacological treatments for heart failure with preserved ejection fraction—a systematic review and indirect comparison
Kwadwo Osei Bonsu, Poukwan Arunmanakul, Nathorn Chaiyakunapruk · 2018 · Heart Failure Reviews
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status
Søren Lund Kristensen, Ulrik Madvig Mogensen, Pardeep S. Jhund, Rasmus Rørth, Inder S. Anand, Peter E. Carson, Akshay Suvas Desai, Bertram Pitt, Marc Alan Pfeffer, Scott David Solomon et al. · 2019 · Circulation Heart Failure
Cardiorenal syndrome in heart failure with preserved ejection fraction—an under-recognized clinical entity
Akanksha Agrawal, Mario Naranjo, Napatt Kanjanahattakij, Janani Rangaswami, Shuchita Gupta · 2019 · Heart Failure Reviews
Heart failure: What does ejection fraction have to do with it?
Hiroyuki Iwano, William C. Little · 2013 · Journal of Cardiology
Mortality in heart failure with preserved ejection fraction: an unacceptably high rate
Daniel Burkhoff · 2011 · European Heart Journal
Management of Heart Failure in Patients with Chronic Kidney Disease
David K Ryan, Debasish Banerjee, Fadi Jouhra · 2022 · European Cardiology Review
Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model
Yohei Sotomi, Shungo Hikoso, Daisaku Nakatani, Katsuki Okada, Tomoharu Dohi, Akihiro Sunaga, Hirota Kida, Taiki Sato, Yuki Matsuoka, Tetsuhisa Kitamura et al. · 2023 · Heart
Sex-related similarities and differences in responses to heart failure therapies
Janice Y. Chyou, Hailun Qin, Javed Butler, Adriaan A. Voors, Carolyn S.P. Lam · 2024 · Nature Reviews Cardiology
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials
Christopher J. Rush, Ross T. Campbell, Pardeep S. Jhund, Eugene C. Connolly, David Preiss, Roy S. Gardner, Mark Colquhoun Petrie, John J.V. McMurray · 2015 · JACC Heart Failure
The value of telemonitoring and ICT-guided disease management in heart failure: Results from the IN TOUCH study
Imke H. Kraai, Arjen de Vries, Karin Marianne Vermeulen, Vincent M. van Deursen, Martje van der Wal, Richard De Jong, René B. van Dijk, Tiny Jaarsma, Hans L. Hillege, Ivonne Lesman · 2015 · International Journal of Medical Informatics
Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction
Marjan U. Mujib, Kanan Patel, Gregg C. Fonarow, Dalane W. Kitzman, Yan Zhang, Inmaculada Aban, O. James Ekundayo, Thomas E. Love, Meredith L. Kilgore, Richard M. Allman et al. · 2013 · The American Journal of Medicine
New Management Strategies in Heart Failure
ANJALI TIKU OWENS, Susan C. Brozena, Mariell L Jessup · 2016 · Circulation Research
Application of an Exercise Intervention on the Evolution of Diastolic Dysfunction in Patients With Diabetes Mellitus
James Hare, M. Hordern, Rodel Leano, Tony Stanton, Johannes B. Prins, Thomas Hugh Marwick · 2011 · Circulation Heart Failure
Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2
Jaqueline Soares da Silva, Daniele Gabriel‐Costa, Hao Wang, Sarfaraz Ahmad, Xuming Sun, Jasmina Varagić, Roberto T. Sudo, Carlos Maria Ferrario, Louis J. Dell' Italia, Gisele Zapata‐Sudo et al. · 2017 · Journal of the Renin-Angiotensin-Aldosterone System
The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more?
Marijana Tadić, Cesare Cuspidi, Athanasios Frydas, Guido M. Grassi · 2018 · Heart Failure Reviews
Effects of coenzyme Q10 supplementation on diastolic function in patients with heart failure with preserved ejection fraction
Mochamad Ali Sobirin, Yan Herry, Sefri Noventi Sofia, Ilham Uddin, Sodiqur Rifqi, Hiroyuki Tsutsui · 2019 · Drug Discoveries & Therapeutics
Heart failure with reduced and preserved ejection fraction in adult congenital heart disease
Sumeet S. Vaikunth, George K. Lui · 2019 · Heart Failure Reviews
Heart failure with preserved ejection fraction: Similarities and differences between women and men
Carl J. Pepine, C. Noel Bairey Merz, Stephanie C. El Hajj, Keith C. Ferdinand, Michèle A. Hamilton, Kathryn J. Lindley, Michael Douglas Nelson, Odayme Quesada, NANETTE KASS WENGER, Jerome L. Fleg · 2020 · International Journal of Cardiology
Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction
Toshiki Kuno, Hiroki A. Ueyama, Tomohiro Fujisaki, Artemis A. Briasouli, Hisato Takagi, Αlexandros Briasoulis · 2020 · The American Journal of Cardiology
Right ventricle in heart failure with preserved ejection fraction
Felix Berglund, Pamela Piña, Cesar José Herrera · 2020 · Heart
Characterization of hemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography stress test
Nicola Riccardo Pugliese, Nicolò De Biase, Alessio Balletti, Francesco Filidei, Alessandra PIERONI, Gennaro D’ANGELO, Silvia Armenia, Matteo Mazzola, Luna Gargani, Lavinia Del Punta et al. · 2021 · Minerva Cardiology and Angiology
Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes
Tomoya Ueda, Shu Kasama, Masahiro Yamamoto, Tomoya Nakano, Kazuhiro Ueshima, Yoshinobu Morikawa, Hiroyuki Kawata, Akiomi Yoshihisa, Masafumi Nakayama, Sei Komatsu et al. · 2021 · Circulation Reports
Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients
Patrick Barry Mark, Kenneth Mangion, Alastair J. Rankin, Elaine Rutherford, Ninian N. Lang, Mark Colquhoun Petrie, Sokratis Stoumpos, Rajan Kantilal Patel · 2022 · Clinical Kidney Journal
Cardiovascular Pathophysiology in Chronic Kidney Disease: Opportunities to Transition from Disease to Health
Matthew Ian Tomey, Jonathan A. Winston · 2014 · Annals of Global Health
Diastolic heart failure: predictors of mortality.
Saadia Sherazi, Wojciech Zaręba · 2011 · PubMed
The Role of Arterial Stiffness and Central Hemodynamics in Heart Failure
Thomas Weber · 2020 · International Journal of Heart Failure
Different Pathophysiology and Outcomes of Heart Failure With Preserved Ejection Fraction Stratified by K-Means Clustering
Daisuke Harada, Hidetsugu Asanoi, Takahisa Noto, Junya Takagawa · 2020 · Frontiers in Cardiovascular Medicine
Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction
Dong-Hyuk Cho, Byung‐Su Yoo · 2021 · Heart Failure Clinics
National Patterns of Heart Failure Hospitalizations and Mortality by Sex and Age
Fátima Rodríguez, Yun Wang, Caitlin E. Johnson, JoAnne Micale Foody · 2013 · Journal of Cardiac Failure
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction
S. Kalantari Tannenbaum, GABRIEL T. SAYER · 2015 · Current Opinion in Cardiology
Disparities in Heart Failure and other Cardiovascular Diseases among Women
Jean C. McSweeney, Christina Bricker, Leanne L. Lefler, Seongkum Heo · 2012 · Women s Health
Optimizing the Management of Heart Failure With Preserved Ejection Fraction in the Elderly by Targeting Comorbidities (OPTIMIZE-HFPEF)
Michael L.X. Fu, Jingmin Zhou, Erik Östgärd Thunström, Torbjörn Almgren, Ludger Grote, Entela Bollano, Maria Schaufelberger, Magnus Carl Johansson, Max Petzold, Karl B Swedberg et al. · 2016 · Journal of Cardiac Failure
Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study
Silvana Kontogeorgos, Erik Östgärd Thunström, Magnus Carl Johansson, Michael L.X. Fu · 2017 · International Journal of Cardiology
Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations
Julio A. Chirinos · 2017 · Journal of Cardiovascular Translational Research
Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Chicago, Estados Unidos, 12-15 de noviembre de 2006)
Javier Bermejo, Javier Segovia, Magda Heras, Fernándo Alfonso · 2007 · Revista Española de Cardiología
“Malignant” Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi‐Ethnic Study of Atherosclerosis)
Matthew N. Peters, Stephen L. Seliger, Robert H. Christenson, Susie Nam Hong-Zohlman, Lori B. Daniels, João A.C. Lima, James A. de Lemos, Ian J. Neeland, Christopher R. deFilippi · 2018 · Journal of the American Heart Association
Heart failure with preserved ejection fraction: A systemic disease linked to multiple comorbidities, targeting new therapeutic options
Yves Juillière, Clément Venner, Laura Filippetti, Batric Popovic, Olivier Huttin, Christine Selton‐Suty · 2018 · Archives of cardiovascular diseases
Why Clinicians Should Care About the Cardiac Interstitium
Erik B. Schelbert, Javed Butler, Javier Dı́ez · 2019 · JACC. Cardiovascular imaging
Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach
Antoni Bayés‐Genís, Felipe Bisbal, Julio E. Núñez, Enrique Santas, Josep Lupón, Patrick Rossignol, Walter J. Paulus · 2020 · Journal of Clinical Medicine
Beneficial and harmful effects of sacubitril/valsartan in patients with heart failure: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
Emil Eik Nielsen, Joshua Buron Feinberg, Fan-Long Bu, Michael Hecht Olsen, Ilan E. Raymond, Frank Steensgaard-Hansen, Janus Christian Jakobsen · 2020 · Open Heart
Renin-Angiotensin Inhibition in Diastolic Heart Failure and Chronic Kidney Disease
Ali Ahmed, Michael W. Rich, Michael R. Zile, Paul W. Sanders, Kanan Patel, Yan Zhang, Inmaculada Aban, Thomas E. Love, Gregg C. Fonarow, Wilbert S. Aronow et al. · 2013 · The American Journal of Medicine
Different Potencies of Angiotensin Receptor Blockers at Suppressing Adrenal β-Arrestin1–Dependent Post-Myocardial Infarction Hyperaldosteronism
Anastasios Lymperopoulos, Emmanuel Sturchler, Ashley Siryk, Samalia Dabul, Dilayda Garcia, Karlee Walklett, Giuseppe Rengo, Patricia H. McDonald, Walter J. Koch · 2014 · Journal of the American College of Cardiology